To include your compound in the COVID-19 Resource Center, submit it here.

Tipranavir: Phase IIb

Twenty-four week data from a double-blind, international Phase IIb trial of tipranavir in combination with

Read the full 151 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE